Home > Services > Clinical Research Studies > Clinical Trials Details
<< Back to Results
This randomized phase II trial is studying giving bendamustine hydrochloride and rituximab together with or without bortezomib followed by rituximab with or without lenalidomide to see how well they work in treating patients with high-risk stage II, stage III, or stage IV follicular lymphoma.
Essentia Health Brainerd, Essentia Health Duluth, Essentia Health Fargo
For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.